Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Laura, Moi"'
Publikováno v:
Allergology International, Vol 73, Iss 1, Pp 143-150 (2024)
Background: Most hospitals use electronic health records (EHR) to warn health care professionals of drug hypersensitivity (DH) and other allergies. Indiscriminate recording of patient self-reported allergies may bloat the alert system, leading to unj
Externí odkaz:
https://doaj.org/article/7297cb422fea4c82b5a5a7edecfa4937
Autor:
Lucrezia Mencarelli, Laura Moi, Natacha Dewarrat, Matteo Monti, Lorenzo Alberio, Maxime Ringwald, Karolina Swierdzewska, Antiochos Panagiotis, Camillo Ribi
Publikováno v:
Vaccines, Vol 11, Iss 8, p 1335 (2023)
During one of the worst global health crises, millions of people were vaccinated against SARS-CoV-2. In rare cases, new onset systemic inflammatory diseases were reported with temporal coincidence to the vaccination. We describe a case of severe Eosi
Externí odkaz:
https://doaj.org/article/58709f7704294fd1b62b1bb99cab444a
Autor:
Sarah Iuliano, Laurence Senn, Laura Moi, Yannick D. Muller, Camillo Ribi, Guillaume Buss, Denis Comte
Publikováno v:
Frontiers in Allergy, Vol 3 (2022)
Beta-lactam allergy is a common problem in everyday medical practice and is recognized as a major public health issue. Carrying this label frequently leads to the avoidance of all beta-lactam antibiotics, favoring the use of other less preferred clas
Externí odkaz:
https://doaj.org/article/ff87d81936094bd8b5ed5b8a76c68ba2
Publikováno v:
Lupus Science and Medicine, Vol 7, Iss 1 (2020)
Externí odkaz:
https://doaj.org/article/29cc7d1e30184ad2bc08776615c2e55f
Autor:
Leo Caratsch, Caroline Schnider, Laura Moi, Katerina Theodoropoulou, Fabio Candotti, Michaël Hofer
Publikováno v:
Revue Médicale Suisse. 18:669-673
Publikováno v:
Revue Médicale Suisse. 18:639-645
Autor:
Beatriz, Sánchez Álamo, Laura, Moi, Ingeborg, Bajema, Mikkel, Faurshou, Oliver, Flossmann, Thomas, Hauser, Zdenka, Hruskova, David, Jayne, Raashid, Luqmani, Alfred, Mahr, Anna, Åkesson, Kerstin, Westman
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
Despite newer treatments with immunosuppressive agents, there still exists a considerable morbidity and mortality risk among patients with antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV). Since 1994 the European Vasculitis So
Publikováno v:
Journal of Clinical Immunology. 42:959-961
Publikováno v:
Revue Médicale Suisse. 17:680-683
Autor:
Beatriz Sanchez Alamo, Laura Moi, Alfred Mahr, Zdenka Hrušková, Ingeborg M. Bajema, Carin Wallquist, David Jayne, Kerstin W.A. Westman
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Patients with ANCA-associated vasculitis (AAV) are known to have an increased risk for the development of malignancies, which has been largely attributed to immunodeficiency or side effects induced by immunosuppressive treatments.